BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16827797)

  • 1. Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
    Koukourakis MI; Giatromanolaki A; Polychronidis A; Simopoulos C; Gatter KC; Harris AL; Sivridis E
    Cancer Sci; 2006 Jul; 97(7):582-8. PubMed ID: 16827797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.
    Koukourakis MI; Giatromanolaki A; Simopoulos C; Polychronidis A; Sivridis E
    Clin Exp Metastasis; 2005; 22(1):25-30. PubMed ID: 16132575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis.
    Koukourakis MI; Pitiakoudis M; Giatromanolaki A; Tsarouha A; Polychronidis A; Sivridis E; Simopoulos C
    Cancer Sci; 2006 Oct; 97(10):1056-60. PubMed ID: 16984378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
    Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Bougioukas G; Didilis V; Gatter KC; Harris AL;
    Br J Cancer; 2003 Sep; 89(5):877-85. PubMed ID: 12942121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer.
    Koukourakis MI; Kakouratos C; Kalamida D; Bampali Z; Mavropoulou S; Sivridis E; Giatromanolaki A
    Int J Radiat Biol; 2016 Jul; 92(7):353-63. PubMed ID: 27010533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.
    Koukourakis MI; Giatromanolaki A; Harris AL; Sivridis E
    Cancer Res; 2006 Jan; 66(2):632-7. PubMed ID: 16423989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
    Cleven AH; van Engeland M; Wouters BG; de Bruïne AP
    Cell Oncol; 2007; 29(3):229-40. PubMed ID: 17452775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress.
    Sivridis E; Giatromanolaki A; Koukourakis MI
    J Clin Pathol; 2005 Oct; 58(10):1033-8. PubMed ID: 16189147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor inhibiting HIF1α (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1α pathway.
    Chen T; Ren Z; Ye LC; Zhou PH; Xu JM; Shi Q; Yao LQ; Zhong YS
    Cancer Biol Ther; 2015; 16(2):244-52. PubMed ID: 25602156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
    Giatromanolaki A; Gkegka AG; Pouliliou S; Biziota E; Kakolyris S; Koukourakis M
    Breast Cancer Res Treat; 2022 Jul; 194(1):13-23. PubMed ID: 35482128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos C; Turley H; Talks K; Gatter KC; Harris AL
    Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1192-202. PubMed ID: 12128120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Pastorek J; Karapantzos I; Gatter KC; Harris AL;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):67-71. PubMed ID: 15093900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
    Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
    J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia inducible factor 1 alpha and 2 alpha expression is independent of anemia in patients with stage I endometrial cancer.
    Koukourakis MI; Giatromanolaki A; Liberis V; Sivridis E
    Anticancer Res; 2002; 22(6C):4137-40. PubMed ID: 12553044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis.
    Cleven AH; Wouters BG; Schutte B; Spiertz AJ; van Engeland M; de Bruïne AP
    Br J Cancer; 2008 Sep; 99(5):727-33. PubMed ID: 18728663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
    Joshi S; Singh AR; Zulcic M; Durden DL
    Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.